Instituto Nazionale Tumori (INT)

CONSORTIUM

The National Cancer Institute of Milan (INT) is recognized as a leading cancer center in Italy. It has been evaluated as the foremost national IRCCS, judging from its achieved results and based on the ranking system adopted by the Italian Ministry of Health to grant funds through its “Institutional funding” program. It is a comprehensive cancer center whose activities range from epidemiology to cancer diagnosis, treatment, rehabilitation and palliative care through innovative therapies and prevention strategies, with Experimental and Clinical Units located in the same or nearby buildings favoring the continuous interactions with Centralized Services.

Role in CCE_DART

INT has a long-standing proven track record in the design and conduction of clinical trials and is a national reference center in the national cancer care panorama. INT presently has 667 ongoing clinical trials, funded by both national an international public and private agencies.